Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2024-06-06 Proxy Solicitation & In…
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
关于召开2024年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice about convening the 2024 first extraordinary general meeting (临时股东大会) of shareholders for 葵花药业集团股份有限公司. It includes information about the meeting date, location, agenda items (such as election of board members, amendments to company articles, and management rules), voting procedures including cumulative voting, registration details, and proxy forms. The document does not contain financial statements or results but is a formal announcement to shareholders about the meeting and how to participate and vote. This matches the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings. It is not an Annual Report, Board/Management change announcement, or Earnings Release. The length and detail confirm it is not a brief announcement but a full meeting notice and proxy solicitation document.
2024-06-06 Chinese
对外担保管理制度（2024年6月）
Governance Information Classification · 95% confidence The document is titled '对外担保管理制度' which translates to 'External Guarantee Management System' and outlines detailed internal policies and procedures for the company's external guarantees, including risk control, approval processes, responsibilities, and legal compliance. It references relevant laws and regulatory guidelines but does not contain financial statements, audit results, or financial performance data. It is a governance-related internal control document rather than a financial report, announcement, or regulatory filing. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2024-06-06 Chinese
关联交易管理制度（2024年6月）
Governance Information Classification · 95% confidence The document is titled '关联交易管理制度' which translates to 'Related Party Transactions Management System'. It details the company's internal rules and procedures for managing related party transactions, including definitions, decision-making processes, disclosure requirements, and governance related to such transactions. It references relevant laws and stock exchange rules, and it is a governance document rather than a financial report or announcement. The document is comprehensive and regulatory in nature but does not contain financial statements, earnings data, or voting results. It is not an announcement of a report but a formal governance policy. Therefore, the most appropriate classification is Governance Information (CGR).
2024-06-06 Chinese
董事会议事规则（2024年6月）
Governance Information Classification · 100% confidence The document is titled 葵花药业集团股份有限公司董事会议事规则, which translates to 'Sunflower Pharmaceutical Group Co., Ltd. Board Meeting Rules.' It details the internal rules, procedures, and governance structure for the company's board meetings, including composition, responsibilities, meeting notices, voting procedures, and record-keeping. There is no financial data, audit information, or report content. It is a governance document outlining board structure and practices, consistent with governance information filings. The document length is 9893 characters, indicating a full governance report rather than a brief announcement. Therefore, the appropriate classification is Governance Information (CGR).
2024-06-06 Chinese
提名人声明与承诺（赵燕）
Board/Management Information Classification · 95% confidence The document is a formal public statement from the board of directors nominating an independent director candidate for the company's board. It includes detailed declarations and commitments regarding the nominee's qualifications, independence, and compliance with relevant laws and regulations. There is no financial data, no discussion of financial results, no mention of shareholder voting results, or any other report content. The document is a regulatory announcement related to board/management information, specifically about a nomination for the board of directors. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is 3465 characters, which is consistent with a detailed announcement rather than a full report.
2024-06-06 Chinese
期货套期保值业务管理制度（2024年6月）
Governance Information Classification · 95% confidence The document is titled as a management system for futures hedging business of the company, detailing internal control policies, organizational structure, approval authority, risk management, reporting, and accounting policies related to futures hedging activities. It is a detailed internal policy document rather than a financial report, earnings release, or announcement. It does not contain financial statements, earnings data, or voting results. It is not a regulatory filing or announcement of a report publication. The document is a governance-related internal control and risk management policy, which fits best under Governance Information (CGR).
2024-06-06 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.